pulmonx.comHealthcareFunding to Date: $226.39MM
Pulmonx is the developer of the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema.
For more details on financing and valuation for Pulmonx, register or login.
View Enterprise Value for Pulmonx.
To read this article and more news on Pulmonx, register or login.